<DOC>
	<DOCNO>NCT01922505</DOCNO>
	<brief_summary>The purpose study investigate trend eradication rate first-line triple therapy Helicobacter pylorus recent ten year clinical factor affect eradication Korean .</brief_summary>
	<brief_title>Eradication Rates Helicobacter Pylori Its Affecting Factors</brief_title>
	<detailed_description>A PPI triple regimen combine proton pump inhibitor ( PPI ) two antibiotic ( amoxicillin clarithromycin ) currently consider gold standard therapy eradication H. pylorus . However , recently eradication rate first-line treatment tendency decrease increase antibiotic resistance . In addition , PPI mainly metabolize cytochrome p450 2C19 ( CYP2C19 ) liver several report suggest difference th CYP2C19 genotype associate H. pylorus eradication failure . Thus , first aim study investigate trend eradication rate first-line triple therapy recent ten year . And second aim analyze antibiotic resistance rate H. pylorus use culture minimal inhibitory concentration ( MICs ) result analyze association CYP2C19 genotype eradication rate H.pylori . And also investigate clinical factor ( age , gender , underlie disease , cigarette smoking alcohol use ) affect eradication rate .</detailed_description>
	<mesh_term>Helicobacter Infections</mesh_term>
	<criteria>Patients prove H. pylorus infection invasive noninvasive H. pylorus test Patients treat Firstline triple therapy ( PPI + Amoxicillin + Clarithromycin ) Previous eradication therapy H. pylorus Followup loss patient eradication therapy Other treatment regimen Poor medication compliance ( &lt; 80 % )</criteria>
	<gender>All</gender>
	<minimum_age>16 Years</minimum_age>
	<maximum_age>92 Years</maximum_age>
	<verification_date>August 2013</verification_date>
</DOC>